These markers are also positive in other cancers such as prostate adenocarcinoma (Her2/erbB2, CK7 and GCDFP15) [33–35] and colon cancer (Her2/erbB2 and CEA) [34, 36, 37]. Here, ERBB2 is linked to prostate adenocarcinoma.